- Home
- / PHOENIX Pharmahandel
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PHOENIX Pharmahandel financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
€30.7 B
FY, 2022
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 27.3B | 28.2B | 30.7B |
| Cost of goods sold | 24.4B | 25.2B | 27.5B |
| Gross profit | 2.9B | 3.0B | 3.2B |
| Gross profit margin, % | 10.7% | 10.7% | 10.5% |
| General and administrative expense | 1.5B | 1.6B | 1.7B |
| Operating expense total | 2.6B | 2.7B | 2.9B |
| Depreciation and amortization | 273.5M | 285.9M | 290.7M |
| EBITDA | 606.5M | 654.9M | 670.1M |
| EBITDA margin, % | 2.2% | 2.3% | 2.2% |
| EBIT | 165.7M | 346.7M | 357.6M |
| EBIT margin, % | 0.6% | 1.2% | 1.2% |
| Interest income | 17.8M | 14.8M | 18.9M |
| Interest expense | 75.4M | 66.4M | 76.7M |
| Pre tax profit | 103.9M | 297.6M | 304.5M |
| Income tax expense | 68.8M | 71.7M | 86.2M |
| Net Income | 35.1M | 225.9M | 218.3M |